Understanding Factors Influencing COVID-19 Testing and Vaccination in Immigrant Low-income and Homeless Populations and Testing Targeted Interventions
Project Number3U54GM115516-05S2
Former Number3U54GM115516-04S2
Contact PI/Project LeaderROSEN, CLIFFORD JAMES Other PIs
Awardee OrganizationMAINEHEALTH
Description
Abstract Text
The COVID-19 pandemic has disproportionately affected people from vulnerable and disadvantaged
communities. Research to date has highlighted the factors that contribute to these disparities including
differential treatment and experience of marginalized populations in healthcare and research settings, reduced
access to testing and care, living in congregate or multigenerational households, the economic consequences
of being diagnosed with COVID-19 and quarantining, differing understanding of and attitudes towards the
pandemic, and concerns about contact tracing. Immigrant and low income populations, and people
experiencing homelessness, many with mental illnesses, and/or have been recently incarcerated, are hesitant
to participate in testing and to accept COVID-19 testing and vaccination. There is an urgent need to
understand how to deliver information about testing and vaccination that is understandable and resonates with
higher risk communities in their cultural and social contexts. Effective public health strategies for delivering this
information must include community input and partnerships. Working closely with community partners who
have insight into cultural, behavioral, economic, and factors impacting people’s decision making about testing
and vaccine acceptance is essential to developing effective communication and outreach strategies for
engaging individuals in testing, vaccination, and care. Working with our community partners, we will create and
evaluate the impact of a public health intervention in the area of Cumberland County, Maine, to provide
outreach, testing, and vaccination education to a large community of immigrants from sub-Saharan Africa, the
Middle East, and Central America, higher-risk low-income people accessing a public health facility (with a
sexually transmitted infections clinic, needle exchange, and a free clinic), and individuals experiencing
homelessness. This will be a longitudinal study to understand beliefs about and knowledge of COVID-19, and
barriers and beliefs about testing and vaccination. Results will inform a community-developed and based
intervention to engage the cohort and other members of these populations in testing and vaccine education,
and evaluate the impact of this intervention on testing and vaccination uptake in our immigrant, low-income,
and homeless communities. Specific Aims: 1) To understand patient perceptions of, fears about, and
experiences with COVID-19 testing and vaccination, including booster vaccination in our immigrant, low-
income, and homeless populations. 2) To use the data from Aim 1 to develop and pilot test a public health
messaging and testing program to increase vaccine and testing uptake in our populations of interest. 3) To
evaluate the impact of a public health messaging and testing program developed in Aim 2 on rapid COVID-19
testing and vaccine uptake. While it will need to be adapted based on local communities’ cultures and needs,
this work could be foundational for creating and sustaining public health measures that will contribute to the
control of the pandemic and reducing the COVID-19 related disparities of vulnerable populations in the US.
Public Health Relevance Statement
The Covid19 pandemic has revealed major health disparities in vulnerable populations, including immigrants,
and persons with low-income or experiencing homelessness. The project will address the cultural, social and
economic barriers to testing and vaccination among these groups. We expect results to provide a model of
interventions that can be adapted for other vulnerable communities to reduce fear of testing and vaccine
hesitancy.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AddressAffectAfrica South of the SaharaAreaAttitudeBeliefCOVID-19COVID-19 diagnosisCOVID-19 pandemicCOVID-19 testingCOVID-19 vaccinationCOVID-19 vaccineCaringCentral AmericaClinicCommunicationCommunitiesContact TracingCountyDataDecision MakingDisadvantagedDropsEconomic FactorsEconomicsEducationExposure toFamilyFeedbackFoundationsFrightHealthHealth Care ResearchHealth care facilityHomelessnessHouseholdImmigrantImprisonmentIndividualInterventionInterviewJusticeKnowledgeLearningLongitudinal StudiesLow Income PopulationLow incomeMaineMeasuresMental disordersMiddle EastModelingNeedle-Exchange ProgramsPatientsPerceptionPersonsPopulationPublic HealthQualitative MethodsQuarantineResearchSARS-CoV-2 infectionSecondary ImmunizationSexually Transmitted DiseasesSiteSocial EnvironmentStructureSuggestionSurveysTestingTimeUnited StatesVaccinatedVaccinationVaccinesVulnerable PopulationsWorkbasebehavioral economicscohortexpectationexperiencehealth disparityhigh riskinsightinterestmarginalized populationmemberoutreachpandemic diseasepreferenceprogramspublic health interventionrapid testingsocialsocial stigmatesting uptakevaccine acceptancevaccine hesitancy
No Sub Projects information available for 3U54GM115516-05S2
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 3U54GM115516-05S2
Patents
No Patents information available for 3U54GM115516-05S2
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 3U54GM115516-05S2
Clinical Studies
No Clinical Studies information available for 3U54GM115516-05S2
News and More
Related News Releases
No news release information available for 3U54GM115516-05S2
History
No Historical information available for 3U54GM115516-05S2
Similar Projects
No Similar Projects information available for 3U54GM115516-05S2